Abstract
This commentary explores the challenges surrounding the development of a standard definition of lymphedema and method of quantification, proposes solutions, and calls for a collaborative effort among providers who care for patients with breast cancer.
MeSH terms
-
Breast Neoplasms / complications
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / pathology
-
Early Detection of Cancer / standards
-
Female
-
Humans
-
Lymphedema / chemically induced
-
Lymphedema / diagnosis*
-
Lymphedema / etiology
-
Lymphedema / pathology